BIOMAT Database Logo BIOMAT Database Logo

[Effects and complications of continuous hepatic arterial infusion chemotherapy using implantable reservoir for liver metastases from colorectal cancer]. 1991

H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
2nd Dept. of Surgery, School of Medicine, Yokohama City University.

Continuous arterial infusion chemotherapy using implantable reservoir was performed for unresectable liver metastases from colorectal cancer and the therapeutic effects, side effects and complications were evaluated. Eleven patients were treated with four kinds of arterial infusion courses that mainly consisted of 5-FU. The arterial infusion courses were discontinued in 2 patients because of nausea and vomiting, and in one patient because of diarrhea. The catheters were dislocated in 2 patients and another 2 developed fistulous between the hepatic artery and bile duct. Three patients developed duodenal ulcer. Serum CEA was reduced in 4 patients (36%). After all, response rate was 9% (1/11). The one-year survival rates of all cases and cases treated with more than 4 courses were 36.3% and 80.0%, respectively.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D004868 Equipment Failure Failure of equipment to perform to standard. The failure may be due to defects or improper use. Defects, Equipment,Device Failure,Failure, Equipment,Malfunction, Equipment,Medical Device Failure,Misuse, Equipment,Device Failure, Medical,Device Failures, Medical,Failure, Medical Device,Failures, Medical Device,Defect, Equipment,Device Failures,Equipment Defect,Equipment Defects,Equipment Failures,Equipment Malfunction,Equipment Malfunctions,Equipment Misuse,Equipment Misuses,Failure, Device,Failures, Device,Failures, Equipment,Malfunctions, Equipment,Misuses, Equipment
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006499 Hepatic Artery A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. Arteries, Hepatic,Artery, Hepatic,Hepatic Arteries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Continuous hepatic arterial infusion chemotherapy using implantable reservoir in liver metastases from colorectal cancer].
August 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Hepatic arterial infusion chemotherapy using totally implantable reservoir in liver metastases in colorectal cancer].
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Hepatic arterial infusion chemotherapy using implantable reservoir in colorectal liver metastasis].
August 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Hepatic arterial infusion chemotherapy for liver metastases from colorectal cancer].
December 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer].
July 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Intra-arterial infusion chemotherapy using an implantable reservoir in the treatment of hepatic metastases in colorectal cancer].
August 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Treatment of liver metastases from colorectal cancer--major hepatic resection and continuous hepatic arterial infusion chemotherapy].
April 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Hepatic arterial infusion chemotherapy for colorectal liver metastases].
May 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
[Arterial infusion cancer chemotherapy in liver tumor using implantable reservoir].
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kurosawa, and S Ohki, and T Joh, and S Imai, and K Matsuo, and S Yamaguchi, and M Fukano, and S Hasegawa, and T Tokitoh, and H Masui
Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.
January 2006, Cancer control : journal of the Moffitt Cancer Center,
Copied contents to your clipboard!